It’s the first time Kay Scarpetta has made it to the screen; while there are nifty plot techniques, the hunt for a serial killer overshadows all.

Agilent acquires Biocare for $950M to boost pathology/cancer diagnostics and recurring revenue. Click here to read an analysis of A stock now.

What on earth is going on? This is the question that kept coming to mind while watching Scarpetta, Nicole Kidman’s new series in which she plays a brilliant but haunted forensic pathologist ...

When Jamie Lee Curtis' blockbuster film “True Lies” premiered worldwide, it would've been improbable to think that 30 years ...

Escalating tensions in the Middle East are triggering supply chain shocks. Yet, it is business as usual for Indian founders in the region.

MGI Tech Co., Ltd. ('MGI'), a company dedicated to developing core tools and technologies that drive innovation in the life ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...

Researchers at the University of Michigan have discovered that the constant gnawing of rodents isn't just a reflex or a consequence of a tough diet. It also triggers a release of dopamine in the brain ...

March 10 2026: Your evening catch-up on the news making the headlines ...

Aiforia Technologies Plc, Press Release, March 10, 2026 at 10:00 a.m. EET Aiforia and Proscia partner to accelerate AI-driven digital pathology Aiforia, a pioneer in AI-driven diagnostics in pathology ...

Agilent Technologies Inc. A shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Synergies Biocare Medical has been a ...

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.